Global Innovative Platforms (GIPL) Asset Utilization Ratio (2025 - 2026)
Global Innovative Platforms' (GIPL) quarterly Asset Utilization Ratio came in at 0.33 in Q2 2026, down 0.96% quarter-over-quarter from 0.33 in Q1 2026.
Analysis
Global Innovative Platforms (GIPL) Asset Utilization Ratio (2025 - 2026) Analysis & Trends
Global Innovative Platforms has disclosed Asset Utilization Ratio across 2 years of filings, most recently posting 0.33 for Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Idexx Laboratories | 39.99 Bn | 39.79 Bn | 779.09 Mn | 1.33 |
| 2 | Zoetis | 30.50 Bn | 28.83 Bn | 1.05 Bn | 0.63 |
| 3 | Elanco Animal Health | 11.44 Bn | 10.91 Bn | 798.00 Mn | 0.37 |
| 4 | Phibro Animal Health | 1.48 Bn | 1.40 Bn | 134.40 Mn | 1.03 |
| 5 | Immucell | 89.38 Mn | 80.52 Mn | 2.44 Mn | 0.60 |
| 6 | Zhengye Biotechnology Holding | 74.34 Mn | 67.24 Mn | - | - |
| 7 | Global Innovative Platforms | 24.88 Mn | 24.63 Mn | - | 0.33 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 0.33 |
| Mar 31, 2026 | 0.33 |
| Dec 31, 2025 | 0.14 |